Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

NEW YORK, Feb. 7 (UPI) --Medications that treat erectile dysfunction may be tied to a lower risk of Alzheimer's disease, a new study indicates. The study was published Wednesday in the online ...

A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...

The study followed over 269,000 participants for five years, and those who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than those who weren’t.

Results of the study, conducted by Eli Lilly & Company, will be presented during the 41st Annual Meeting of The Obesity Society at ObesityWeek® 2023 scheduled for Oct. 14–17, in Dallas, Texas.

Highest dose of tirzepatide reduced A1C by 2.58 percent and body weight by 11.7 kg (25.8 lb., 13.0 percent) SURPASS program has now met regulatory submission requirements for evaluating ...

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 weeks, people who took tirzepatide lost an average of 50 pounds. Here's ...